Faecal calprotectin in colonic diverticular disease: A case-control study

International Journal of Colorectal Disease

Volumn 24, Issue 1, 2009, Pages 49-55

  Tursi, Antonio ^a   Brandimarte, Giovanni ^b   Elisei, Walter ^b   Giorgetti, Gian Marco ^c   Inchingolo, Cosimo Damiano ^a   Aiello, Fabio ^d  

^a Lorenzo Bonomo Hospital   (Italy)

^b Cristo Re Hospital   (Italy)

^c S EUGENIO HOSPITAL   (Italy)

^d UNIVERSITY OF PALERMO   (Italy)

Author keywords

Diverticular disease; Faecal calprotectin; Irritable bowel syndrome; Microscopic inflammation

Indexed keywords

CALGRANULIN;

ABDOMINAL PAIN; ADULT; ARTICLE; CLINICAL ARTICLE; COLONOSCOPY; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DIVERTICULOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IRRITABLE COLON; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; COLONOSCOPY; DIVERTICULOSIS, COLONIC; FECES; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; IRRITABLE BOWEL SYNDROME; LEUKOCYTE L1 ANTIGEN COMPLEX; LYMPHOCYTES; MALE; MESALAMINE; MIDDLE AGED; NEUTROPHILS; RIFAMYCINS; SEVERITY OF ILLNESS INDEX;

EID: 57049114317     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-008-0595-9     Document Type: Article

References (27)

1. Floch MH, Bina I (2004) The natural history of diverticulitis: Fact and theory. J Clin Gastroenterol 38(suppl. 5):2-7
2. Tursi A (2004) Acute diverticulitis of the colon - current medical therapeutic management. Expert Opin Pharmacother 5:145-149
3. Tursi A, Brandimarte G, Giorgetti GM, Elisei W, Inchingolo CD, Danese S, Aiello F (2008) Assessment and grading of mucosal inflammation in colonic diverticular disease. J Clin Gastroenterol 42:699-703
4. Costa F, Mumolo MG, Bellini M, Romano MR, Ceccarelli L, Arpe P, Sterpi C, Marchi S, Maltinti G (2003) Role of faecal calprotectin as non-invasive marker of intestinal inflammation. Dig Liver Dis 35:642-647
5. Tibble JA, Teahon K, Thjodleifssan B et al (2000) A simple method for assessing intestinal inflammation in Crohn's disease. Gut 47:506-513
6. Roseth AG, Aadland E, Jahnsen J, Raknerud N (1997) Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. Digestion 58:176-180
7. Roseth AG, Fagerhol M, Aadland E, Schjonsby H (1992) Assessment of neutrophil dominating protein calprotectin in feces. A methodological study. Scand J Gastroenterol 27:793-798
8. Teahon K, Roseth AG, Foster R, Bjarnason I (1997) fecal calprotectin: A simple sensitive quantitative measure of intestinal inflammation in man. Gastroenterology 112(suppl.):A1103
9. Costa F, Mumolo MG, Ceccarelli L, Bellini M, Romano MR, Sterpi C, Ricciuti A, Marchi S, Bottai M (2005) Calprotectin is stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease. Gut 54:364-368
10. Pezzilli R, Barrassi A, Morselli Labate AM, Tinozzi S, Fantini I, Gizzi G, Latzniker M, Villani V, Melzi D'Eril G, Corinaldesi R (2008) Fecal calprotectin levels in patients with colonic polyposis. Dig Dis Sci 53:47-51
11. Montalto M, Santoro L, Curigliano V, D'Onofrio F, Cammarota G, Panunzi S, Ricci R, Gallo A, Greco A, Gasbarrini A, Gasbarrini G (2007) Faecal calprotectin in untreated coeliac patients. Scand J Gastroenterol 42:957-961
12. Köhler L, Sauerland S, Neugebauer E, for the Scientific Committee of the European Association for Endoscopic Surgery (E.A.E.S.) (1999) Diagnosis and treatment of diverticular disease. Results of a Consensus Development Conference. Surg Endosc 13:430-436
13. Pereira JM, Sirlin CB, Pinto PS, Jeffrey RB, Stella DL, Casola G (2004) Disproportionate fat stranding: A helpful CT sign in patients with acute abdominal pain. RadioGraphics 24:703-715
14. Tursi A, Brandimarte G, Giorgetti GM, Elisei W, Maiorano M, Aiello F (2008) The clinical picture of uncomplicated versus complicated diverticulitis of the colon. Dig Dis Sci 53:2474-2479
15. Lamps LW, Knapple WL (2007) Diverticular disease-associated segmental colitis. Clin Gastroenterol Hepatol 5:27-31
16. Thompson WG, Longstreth GF, Drossmann DA, Heaton KW, Irvine EJ, Müller-Lissner SA (1999) Functional bowel disorders and functional abdominal pain. Gut 45(suppl. II):II43-II47
17. Tursi A (2007) New physiopathological and therapeutic approaches to diverticular disease of the colon. Expert Opin Pharmacother 8:299-307
18. Di Mario F, Aragona G, Leandro G, Comparato G, Fanigliulo L, Cavallaro LG, Cavestro GM, Iori V, Maino M, Moussa AM, Gnocchi A, Mazzocchi G, Franzè A (2005) Efficacy of mesalazine in the treatment of symptomatic diverticular disease. Dig Dis Sci 50:581-586
19. Tursi A, Brandimarte G, Giorgetti GM, Elisei W (2006) Mesalazine and/or Lactobacillus casei in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon: A prospective, randomized, open-label study. J Clin Gastroenterol 40:312-316
20. Shitrit AB, Braverman D, Stankiewics H, Shitrit D, Peled N, Paz K (2007) Fecal calprotectin as a predictor of abnormal colonic histology. Dis Colon Rectum 50:2188-2193
21. Tibble JA, Sigthorsson G, Foster R, Forgacs I, Bjarnason I (2002) Use of surrogate markers of inflammation and Rome criteria to distinguish organic from non-organic intestinal disease. Gastroenterology 123:450-460
22. Carroccio A, Iacono G, Cottone M, Di Prima L, Cartabellotta F, Cavataio F, Scalici P, Montalto G, Di Fede G, Ricci G, Notarbartolo A, Averna MR (2003) Diagnostic accuracy of fecal calprotectin assay in distinguish organic causes of chronic diarrhea from irritable bowel syndrome: A prospective study on adults and children. Clin Chem 49:861-867
23. Marsh MN, Crowe PT (1995) Morphology of the mucosal lesion in gluten sensitivity. Baillieres Clin Gastroenterol 9:273-293
24. Tursi A, Brandimarte G, Elisei W, Giorgetti GM, Inchingolo CD, Aiello F (2008) Effect of mesalazine on epithelial cell proliferation in colonic diverticular disease. Dig Liver Dis 40:737-742
25. Desai D, Faubion WA, Sandborn WJ (2007) Review article: Biological activity markers in inflammatory bowel disease. Aliment Pharmacol Ther 25:247-255
26. Langhorst J, Elsencruch S, Koelzer J, Rueffer A, Michalsen A, Dobos GJ (2008) Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: Performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Am J Gastroenterol 103:162-169
27. Vestergaard TA, Nielsen SL, Dahlerup JF, Hornung N (2007) Fecal calprotectin: Assessment of a rapid test. Scand J Clin Lab Invest i:1-5